基本信息·出版社:Academic Press ·页码:800 页 ·出版日期:2008年02月 ·ISBN:0123742161 ·条形码:9780123742162 ·装帧:精装 ·正文语种:英语 ...
商家名称 |
信用等级 |
购买信息 |
订购本书 |
|
 |
Handbook of Fiber Optic Data Communication, Third Edition: A Practical Guide to |
 |
|
 |
Handbook of Fiber Optic Data Communication, Third Edition: A Practical Guide to |
 |

基本信息·出版社:Academic Press
·页码:800 页
·出版日期:2008年02月
·ISBN:0123742161
·条形码:9780123742162
·装帧:精装
·正文语种:英语
内容简介 在线阅读本书
The third edition of this Handbook provides a comprehensive, easy to use guide to the field of optical fiber data communications. Written by experts in the industry from major companies such as IBM, Cisco and Nortel, the Handbook is a key reference for optical fiber technology, networking, protocols, applications, manufacturing, and future directions. It includes chapters on all the major industry standards, written by the same experts who developed them.
This edition contains new material on transceiver form factors (QSFP, SFP +, XFP, X2), manufacturing standards, including JEDEC and RoHS, as well as the latest revisions to industry standards including 8G and 10G Fiber Channel, FICON, SONET GFP/LCAS, and 10 Gigabit Ethernet. The book also contains new chapters on emerging technologies and leading edge applications such as silicon photonics, nanophotonics, parallel optical interconnects, specialty fiber cable types, and optical backplanes.
Features include:
* New Case Studies on Voice/Data Convergence, Redesigning Mainframe I/O, National LambdaRail, and optical peer-to-peer networks
* Includes an expanded listing of references on the World Wide Web, plus hard-to-find references for international, homologation, and type approval requirements
* Quick reference tables of all the key optical network parameters and a glossary that defines hundreds of technical terms and acronyms
* An accompanying website provides an online portal to the data communications community, containing podcasts on key topics, links to related material from technical societies, corporations and other professional organizations
Written for engineers by engineers, this Handbook will be an indispensable, hands-on reference for optical networks and equipment developers, designers, and installers, as well as for students studying optical fiber communications wanting an understanding of, and insight into, professional practice.
* New Case Studies on Voice/Data Convergence, Redesigning Mainframe I/O, National LambdaRail, and optical peer-to-peer networks
* Includes an expanded listing of references on the World Wide Web, plus hard-to-find references for international, homologation, and type approval requirements
* Quick reference tables of all the key optical network parameters and a glossary that defines hundreds of technical terms and acronyms
* An accompanying website provides an online portal to the data communications community, containing podcasts on key topics, links to related material from technical societies, corporations and other professional organizations
作者简介 Camille-Georges Wermuth PhD, Prof. and Founder of Prestwick Chemical, was Professor of Organic Chemistry and Medicinal Chemistry at the Faculty of Pharmacy, Louis Pasteur University, Strasbourg, France from 1969 to 2002. He became interested in Medicinal Chemistry during his two years of military service in the French Navy at the "Centre dEtudes Physio-biologiques Appliquées à la Marine" in Toulon. During this time he worked under the supervision of Dr Henri Laborit, the scientist who invented artificial hibernation and discovered chlorpromazine.
Professor Wermuths main research themes focus on the chemistry and the pharmacology of pyridazine derivatives. The 3-aminopyridazine pharmacophore, in particular, allowed him to accede to an impressive variety of biological activities, including antidepressant and anticonvulsant molecules; inhibitors of enzymes such as mono-amine-oxidases, phosphodiesterases and acetylcholinesterase; ligands for neuro-receptors: GABA-A receptor antagonists, serotonine 5-HT3 receptor antagonists, dopaminergic and muscarinic agonists. More recently, in collaboration with the scientists of the Sanofi Company, he developed potent antagonists of the 41 amino-acid neuropeptide CRF (corticotrophin-releasing factor) which regulates the release of ACTH and thus the synthesis of corticoids in the adrenal glands. Professor Wermuth has also, in collaboration with Professor Jean-Charles Schwartz and Doctor Pierre Sokoloff (INSERM, Paris), developed selective ligands of the newly discovered dopamine D3 receptor. After a three-year exploratory phase, this research has led to nanomolar partial agonists which may prove useful in the treatment of the cocaine-withdrawal syndrome.
Besides about 300 scientific papers and about 60 patents, Professor Wermuth is co-author or editor of several books including; Pharmacologie Moléculaire, Masson & Cie, Paris; Médicaments Organiques de Synthèse, Masson & Cie, Paris; Medicinal Chemistry for the 21st Century, Blackwell Scientific Publications, Oxford; Trends in QSAR and Molecular Modeling, ESCOM, Leyden, two editions of The Practice of Medicinal Chemistry, Academic Press, London and The Handbook of Pharmaceutical Salts, Properties Selection and Use, Wiley-VCH.
Professor Wermuth was awarded the Charles Mentzer Prize of the Société Française de Chimie Thérapeutique in 1984, the Léon Velluz Prize of the French Academy of Science in 1995, the Prix de lOrdre des Pharmaciens 1998 by the French Academy of Pharmacy and the Carl Mannich Prize of the German Pharmaceutical Society in 2000. He is Corresponding Member of the German Pharmaceutical Society and was nominated Commandeur des Palmes Académiques in 1995. He has been President of the Medicinal Chemistry Section of the International union of Pure and Applied Chemistry (IUPAC) from 1988 to 1992 and from January 1998 to January 2000 was President of the IUPAC Division on Chemistry and Human Health.
编辑推荐 Review
"The third edition of this book, useful to seasoned medicinal chemists as well as to chemists entering the academic or industrial laboratories, provides a hands-on overview of the drug discovery process. This edition differs from the previous two editions by having been updated to reflect developments in the past 5 years, and it includes 11 new chapters. I found this book to be unique, well organized, and overall a useful addition to the medicinal chemistry literature. Having favorably reviewed the first edition, I still highly recommend this third edition to all chemists who are involved in the drug discovery process." - John L. Neumeyer, Harvard Medical School, in JOURNAL OF MEDICINAL CHEMISTRY from the American Chemical Society
Review
"The third edition of this book, useful to seasoned medicinal chemists as well as to chemists entering the academic or industrial laboratories, provides a hands-on overview of the drug discovery process. This edition differs from the previous two editions by having been updated to reflect developments in the past 5 years, and it includes 11 new chapters.
I found this book to be unique, well organized, and overall a useful addition to the medicinal chemistry literature. Having favorably reviewed the first edition, I still highly recommend this third edition to all chemists who are involved in the drug discovery process."
- John L. Neumeyer, Harvard Medical School, in JOURNAL OF MEDICINAL CHEMISTRY from the American Chemical Society